Non-invasive uveitis screening, diagnosis and monitoring

Kriba has developed a non-invasive, automatic, AI-powered white blood cell counter that enables worldwide access to accurate screening, diagnosis, monitoring of uveitis, and objective quantification of the disease severity on closed eyelids.
This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.

Kriba generates impact on healthcare worldwide by accelerating non-invasive screening, diagnosis and monitoring of uveitis

Kriba Eyecare logo

Uveitis is a major cause of blindness worldwide. Early detection and accurate treatment monitoring of uveitis can prevent dramatic vision loss and eventual blindness. 

Suspecting uveitis can be challenging because it can present asymptomatically in children and infants with juvenile idiopathic arthritis. Uveitis is also missed by the non-expert clinicians in cases of red eye and conjunctivitis, leading to delayed referrals to specialists. Accurate treatment monitoring is also paramount to avoid clinical complications. This is why accurate and objective quantification of the disease severity is needed.

Due to similarities with other ocular condition, misdiagnosis or delayed treatment is possible, moreover, uveitis is often associated with systemic diseases or infections making diagnosis complex.

Low and middle income regions may also have limited access to advanced diagnostic tools and specialized expertise. This can affect timely and accurate detection of uveitis.
Uveitis screening involves counting white blood cells in the fluid behind the cornea and relies on the expertise of the ophtalmologist. The screening process with Neosonics© is done with the eye closed, the cell count is powered by AI, allowing automatic measurement in 30 seconds, and in can be used inmlow, middle and high income countries.
The device will allow the exploration of patients with specific conditions that were difficult to examine before. Its ubiquity in the health system, especially in eye care units, emergency departments and primary care, will improve early detection of uveitis. This will lead to reduced treatment costs and lower rates of blindness and vision loss associated with uveitis.
Patient Care Icon


Measurements on closed eyelid for patient comfort and probe placement system to switch from eye to eye.


Automated cell count measurement powered by AI
Sensitivity and accuracy Icon

and accuracy

High sensitivity and specificity to accurately screen, diagnose and monitor, especially for patients with nonspecific clinical presentations.


It can be used to perform frequent measurements to track white blood cell count evolution, to monitor the patient’s response to treatment.


Early detection will save costs associated to unnecessary laboratory tests, treatments, hospitalization.

Scientific Publications

Kriba Eye care

Introducing non-invasive and automatic early detection and quantitative monitoring of uveitis.

Are you a healthcare

The content featured on this site is exclusively addressed to healthcare and medical technology specialists. The following products are under development and/or validation processes and they are not ready for commercialization.